- Home
- BDTX vs CRNT Comparison
BDTX vs CRNT Comparison
Compare BDTX & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- CRNT
- Stock Information
- Founded
- BDTX 2014
- CRNT 1996
- Country
- BDTX United States
- CRNT Israel
- Employees
- BDTX N/A
- CRNT N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- BDTX Health Care
- CRNT Technology
- Exchange
- BDTX Nasdaq
- CRNT Nasdaq
- Market Cap
- BDTX 220.3M
- CRNT 228.3M
- IPO Year
- BDTX 2020
- CRNT 2000
- Fundamental
- Price
- BDTX $3.95
- CRNT $2.54
- Analyst Decision
- BDTX Strong Buy
- CRNT Strong Buy
- Analyst Count
- BDTX 5
- CRNT 4
- Target Price
- BDTX $10.40
- CRNT $5.50
- AVG Volume (30 Days)
- BDTX 812.4K
- CRNT 659.3K
- Earning Date
- BDTX 11-05-2025
- CRNT 11-11-2025
- Dividend Yield
- BDTX N/A
- CRNT N/A
- EPS Growth
- BDTX N/A
- CRNT 34.68
- EPS
- BDTX 0.25
- CRNT 0.15
- Revenue
- BDTX $70,000,000.00
- CRNT $380,518,000.00
- Revenue This Year
- BDTX N/A
- CRNT N/A
- Revenue Next Year
- BDTX N/A
- CRNT $7.23
- P/E Ratio
- BDTX $15.76
- CRNT $17.41
- Revenue Growth
- BDTX N/A
- CRNT 5.06
- 52 Week Low
- BDTX $1.20
- CRNT $1.82
- 52 Week High
- BDTX $4.45
- CRNT $5.73
- Technical
- Relative Strength Index (RSI)
- BDTX 55.41
- CRNT 54.45
- Support Level
- BDTX $3.71
- CRNT $2.48
- Resistance Level
- BDTX $4.08
- CRNT $2.84
- Average True Range (ATR)
- BDTX 0.24
- CRNT 0.13
- MACD
- BDTX -0.04
- CRNT 0.01
- Stochastic Oscillator
- BDTX 35.90
- CRNT 42.38
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.